Arcoris bio Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $7.88M

  • Investors
  • 3

Arcoris bio General Information

Description

Developer of nanotechnology reagents and protocols designed for the enhanced and simultaneous detection of RNA and protein within biological samples. The company's platform incorporates a nanotechnology-based signal amplification system that permits real simultaneous multiplex detection of targets, is multimodal for applications such as immunofluorescence and imaging mass cytometry, and is designed for ease of use while requiring no specialized laboratory equipment, enabling scientific researchers in cell biology and genomics to perform accurate, high-throughput biomolecule quantification that complements other data analysis methods like RNA sequencing.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Wagistrasse 25
  • 8952 Schlieren
  • Switzerland
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Corporate Office
  • Wagistrasse 25
  • 8952 Schlieren
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Arcoris bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 06-Nov-2025 $7.88M Completed Startup
To view Arcoris bio’s complete valuation and funding history, request access »

Arcoris bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
To view Arcoris bio’s complete cap table history, request access »

Arcoris bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Arcoris bio Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ventura BioMed Investors Venture Capital Minority
ZEISS Ventures Corporate Venture Capital Minority
Zürcher Kantonalbank Asset Manager Minority
To view Arcoris bio’s complete investors history, request access »

Arcoris bio FAQs

  • When was Arcoris bio founded?

    Arcoris bio was founded in 2022.

  • Where is Arcoris bio headquartered?

    Arcoris bio is headquartered in Schlieren, Switzerland.

  • What is the size of Arcoris bio?

    Arcoris bio has 10 total employees.

  • What industry is Arcoris bio in?

    Arcoris bio’s primary industry is Biotechnology.

  • Is Arcoris bio a private or public company?

    Arcoris bio is a Private company.

  • What is the current valuation of Arcoris bio?

    The current valuation of Arcoris bio is .

  • What is Arcoris bio’s current revenue?

    The current revenue for Arcoris bio is .

  • How much funding has Arcoris bio raised over time?

    Arcoris bio has raised $7.88M.

  • Who are Arcoris bio’s investors?

    Ventura BioMed Investors, ZEISS Ventures, and Zürcher Kantonalbank have invested in Arcoris bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process